Skip to Content
Merck
  • Potassium glutamate as a transcriptional inhibitor during bacterial osmoregulation.

Potassium glutamate as a transcriptional inhibitor during bacterial osmoregulation.

The EMBO journal (2006-03-17)
Jay D Gralla, David R Vargas
ABSTRACT

Potassium glutamate accumulates upon hyper-osmotic shock and serves as a temporary osmoprotectant. This salt leads to transcriptional activation of sets of genes that allow the cell to achieve long-term adaptation to high osmolarity. The current experiments show that potassium glutamate also acts as an inhibitor of bulk cellular transcription. It can do so independent of the involvement of macromolecular repressors or activators by virtue of its ability to directly inhibit RNA polymerase binding to ribosomal promoters. Thus, potassium glutamate mediates a global transcription switch by acting differentially on RNA polymerase at sets of genomic promoters that differ in their built-in direct response to this salt.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Potassium acetate solution, BioUltra, for molecular biology, 5 M in H2O
Sigma-Aldrich
Potassium acetate, meets USP testing specifications
Sigma-Aldrich
Potassium acetate, for molecular biology, ≥99.0%
Sigma-Aldrich
Potassium acetate, BioUltra, for molecular biology, ≥99.0% (NT)
Sigma-Aldrich
Potassium acetate, BioXtra, ≥99.0%
Sigma-Aldrich
Potassium acetate, 99.98% trace metals basis
Sigma-Aldrich
Potassium acetate, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Potassium acetate, ACS reagent, ≥99.0%
Sigma-Aldrich
Potassium acetate, puriss., meets analytical specification of Ph. Eur., BP, E261, 99-101%